PPD Announces Fourth Quarter and Full-Year 2020 Earnings Conference Call
03 Febbraio 2021 - 11:10PM
Business Wire
PPD, Inc. (Nasdaq: PPD), a leading global contract research
organization, will host a conference call on Wednesday, Feb. 24,
2021, at 9 a.m. (U.S. Eastern Time) to discuss its fourth quarter
and full-year 2020 financial results. Investors and other
interested parties may listen to a live webcast of the conference
call by logging on to the investors section of PPD’s website at
https://investors.ppd.com. An archived copy of the webcast will be
available on the website after the call.
In addition, the conference call can be accessed live over the
phone by dialing +1 877 407 0784, or for international callers, +1
201 689 8560. A replay will be available after the call and can be
accessed by dialing +1 844 512 2921, or for international callers,
+1 412 317 6671. The passcode for the live conference call and the
replay is 13715818. The audio replay will be available until
Wednesday, March 10, 2021.
About PPD PPD is a leading global contract research
organization providing comprehensive, integrated drug development,
laboratory and lifecycle management services. Our customers include
pharmaceutical, biotechnology, medical device, academic and
government organizations. With offices in 46 countries and more
than 26,000 professionals worldwide, PPD applies innovative
technologies, therapeutic expertise and a firm commitment to
quality to help customers bend the cost and time curve of drug
development and optimize value in delivering life-changing
therapies to improve health. For more information, visit
www.ppd.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210203005961/en/
Investors: Tracy Krumme +1 910 558 4186 investors@ppd.com
Media: media@ppd.com
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Ott 2023 a Ott 2024
Notizie in Tempo Reale relative a Pharmaceutical Prod Dev (MM) (NASDAQ): 0 articoli recenti
Più Pharmaceutical Prod Dev (MM) Articoli Notizie